Monday, 28 October 2013

Key Safety Questions May Linger for FDA-Expedited Drugs

Study finds medications sped to market are tested on fewer patients, with additional safety studies sometimes overdue via Resurrection Health Care - Daily News More READ
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)